Karen Jean Ferrante Insider Trading $PGNX PROGENICS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Jean Ferrante.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Jean Ferrante. Karen Jean Ferrante is in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in MACROGENICS INC ($MGNX) and Head Res. & Dev. & Chief Med. in Tokai Pharmaceuticals Inc ($TKAI) and Director in Unum Therapeutics Inc. ($UMRX) and Director in Baxalta Inc ($BXLT).
Karen Jean Ferrante in PROGENICS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen Jean Ferrante: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2020
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen Jean Ferrante in PROGENICS PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXLT, COGT, ELDN, MGNX, PGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| Jun 15 2017 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 6.95 | 20,000 | 139,000 | 20,000 | ||
| Jun 09 2016 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 4.89 | 20,000 | 97,800 | 20,000 | ||
| Jun 11 2015 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | A | 6.72 | 20,000 | 134,400 | 20,000 | |
| Jun 19 2014 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.47 | 20,000 | 89,400 | 20,000 | |
| Jan 30 2014 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.50 | 40,000 | 180,000 | 40,000 |
Page: 1